Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)

Fig. 4

KM survival stratification analyses in TCGA-BLCA cohort. a Age ≤ 65 years; b Age > 65 years; c Female; d Male; e Papillary; f Non‐papillary; g Stage I/II; h Stage III/IV; i Pathology T0‐T2; j Pathology T3‐T4; k Pathology N0; l Pathology N + ; m Number of positive lymph nodes by HE −; n Number of positive lymph nodes by HE + ; o Lymphovascular invasion −; p Lymphovascular invasion +

Back to article page